These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 29860457)

  • 41. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of macular microvasculature features before and after vitrectomy in the idiopathic macular epiretinal membrane using a grading system: An optical coherence tomography angiography study.
    Mao J; Xu Z; Lao J; Chen Y; Xu X; Wu S; Zheng Z; Liu B; Shen L
    Acta Ophthalmol; 2021 Nov; 99(7):e1168-e1175. PubMed ID: 33423352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.
    Mimouni M; Segev O; Dori D; Geffen N; Flores V; Segal O
    Am J Ophthalmol; 2017 Oct; 182():160-167. PubMed ID: 28837790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Intravitreal Ranibizumab on Vessel Functionality in Patients With Retinal Vein Occlusion.
    Corvi F; La Spina C; Benatti L; Querques L; Lattanzio R; Bandello F; Querques G
    Am J Ophthalmol; 2015 Jul; 160(1):45-52.e1. PubMed ID: 25896458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion.
    Choi KE; Yun C; Cha J; Kim SW
    Sci Rep; 2019 Oct; 9(1):14153. PubMed ID: 31578437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment.
    Moon BG; Um T; Lee J; Yoon YH
    Ophthalmol Retina; 2018 Mar; 2(3):235-243. PubMed ID: 31047592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlation of capillary plexus with visual acuity in idiopathic macular epiretinal membrane eyes using optical coherence tomography angiography].
    Mao JB; Lao JM; Yu XT; Chen YQ; Tao JW; Wu HF; Cheng D; Chen H; Shen LJ
    Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):757-762. PubMed ID: 31607064
    [No Abstract]   [Full Text] [Related]  

  • 48. Grading of macular perfusion in retinal vein occlusion using en-face swept-source optical coherence tomography angiography: a retrospective observational case series.
    Moussa M; Leila M; Bessa AS; Lolah M; Abou Shousha M; El Hennawi HM; Hafez TA
    BMC Ophthalmol; 2019 Jun; 19(1):127. PubMed ID: 31182069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
    Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
    Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab.
    Asano T; Kunikata H; Yasuda M; Nishiguchi KM; Abe T; Nakazawa T
    Int Ophthalmol; 2021 Jan; 41(1):151-162. PubMed ID: 32894391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome Predictors.
    Guichard MM; Xavier AR; Türksever C; Pruente C; Hatz K
    Ophthalmic Res; 2018; 60(1):29-37. PubMed ID: 29566387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion:
    Pielen A; Feltgen N; Hattenbach LO; Hoerauf H; Bertelmann T; Quiering C; Vögeler J; Priglinger S; Lang GE; Schmitz-Valckenberg S; Wolf A; Rehak M
    Curr Eye Res; 2020 May; 45(5):604-614. PubMed ID: 31665935
    [No Abstract]   [Full Text] [Related]  

  • 54. TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDY.
    Obeid A; Hsu J; Ehmann D; Gao X; Sridhar J; Chiang A; Park CH; Ho AC
    Retin Cases Brief Rep; 2021 Mar; 15(2):120-126. PubMed ID: 29864044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion.
    Wolf-Schnurrbusch UE; Ghanem R; Rothenbuehler SP; Enzmann V; Framme C; Wolf S
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3334-7. PubMed ID: 21087958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinal Hemodynamics Seen on Optical Coherence Tomography Angiography Before and After Treatment of Retinal Vein Occlusion.
    Suzuki N; Hirano Y; Tomiyasu T; Esaki Y; Uemura A; Yasukawa T; Yoshida M; Ogura Y
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5681-5687. PubMed ID: 27784073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
    Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
    Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
    Tadayoni R; Paris LP; Danzig CJ; Abreu F; Khanani AM; Brittain C; Lai TYY; Haskova Z; Sakamoto T; Kotecha A; Schlottmann PG; Liu Y; Seres A; Retiere AC; Willis JR; Yoon YH;
    Ophthalmology; 2024 Aug; 131(8):950-960. PubMed ID: 38280653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.